{
    "root": "52b9369d-2360-4c63-b942-b154c3993e9f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nexterone",
    "value": "20250221",
    "ingredients": [
        {
            "name": "AMIODARONE HYDROCHLORIDE",
            "code": "976728SY6Z"
        },
        {
            "name": "BETADEX SULFOBUTYL ETHER SODIUM",
            "code": "2PP9364507"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "ANHYDROUS DEXTROSE",
            "code": "5SL0G7R0OK"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "nexterone premixed injection indicated initiation treatment prophylaxis frequently recurring ventricular fibrillation ( vf ) hemodynamically unstable ventricular tachycardia ( vt ) patients refractory therapy .",
    "contraindications": "\u2022 recommended starting dosing regimen : ( 2 ) initial load : 150 mg 100 ml infused 10 minutes followed : 1 mg/min 6 hours followed : 0.5 mg/min thereafter \u2022 breakthrough episodes vf hemodynamically unstable vt , repeat initial load ( 2 )",
    "warningsAndPrecautions": "nexterone ( amiodarone hcl ) premixed injection supplied ready-to-use , sterile , nonpyrogenic , iso-osmotic solution 100 ml 200 ml single-dose galaxy containers packaged individual cartons follows : 150 mg/100 ml ndc 43066 \u2013 150 \u2013 10 360 mg/200 ml ndc 43066 \u2013 360 \u2013 20 add supplementary medication nexterone premixed injection . store 20\u00b0 - 25\u00b0c ( 68\u00b0 - 77\u00b0f ) ; excursions permitted 15\u00b0 - 30\u00b0c ( 59\u00b0 - 86\u00b0f ) . usp controlled room temperature . protect light excessive heat . protect freezing . carton protect contents light used .",
    "adverseReactions": "nexterone premixed injection contraindicated patients : \u2022known hypersensitivity components nexterone premixed injection , including iodine [ ( 5.9 ) ] . \u2022cardiogenic shock . \u2022marked sinus bradycardia . \u2022second- third-degree atrioventricular ( av ) block unless functioning pacemaker available .",
    "indications_original": "NEXTERONE Premixed Injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy.",
    "contraindications_original": "\u2022 The recommended starting dosing regimen is: (2) o Initial Load:  150 mg in 100 mL  infused over 10 minutes o Followed by:  1 mg/min for 6 hours o Followed by:  0.5 mg/min thereafter \u2022 For breakthrough episodes of VF or hemodynamically unstable VT, repeat the Initial Load (2)",
    "warningsAndPrecautions_original": "NEXTERONE (amiodarone HCl) Premixed Injection is supplied as a ready-to-use, sterile, nonpyrogenic, iso-osmotic solution in 100 mL and 200 mL single-dose GALAXY containers packaged in individual cartons as follows:\n                  \n                     \n                     \n                     \n                        \n                           \n                              150 mg/100 mL\n                           \n                           \n                              NDC 43066 \u2013 150 \u2013 10\n                           \n                        \n                        \n                           \n                              360 mg/200 mL\n                           \n                           \n                              NDC 43066 \u2013 360 \u2013 20\n                           \n                        \n                     \n                  \n                  Do not add supplementary medication to NEXTERONE Premixed Injection.\n                  Store at 20\u00b0 - 25\u00b0C (68\u00b0 - 77\u00b0F); excursions permitted to 15\u00b0 - 30\u00b0C (59\u00b0 - 86\u00b0F).  See USP Controlled Room Temperature.\n                  Protect from light and excessive heat. Protect from freezing.\n                  Use carton to protect contents from light until used.",
    "adverseReactions_original": "NEXTERONE Premixed Injection is contraindicated in patients with:\n                  \n                     \n                        \u2022Known hypersensitivity to any of the components of NEXTERONE Premixed Injection, including iodine [\n                           see Warnings and Precautions (5.9)\n                        ]. \n                     \n                        \u2022Cardiogenic shock.\n                     \n                        \u2022Marked sinus bradycardia.\n                     \n                        \u2022Second- or third-degree atrioventricular (AV) block unless a functioning pacemaker is available."
}